Development and validation of the mpox stigma scale (MSS) and mpox knowledge scale (MKS).

ABSTRACT:

Background

Few validated brief scales are available to measure constructs that may hinder mpox-related prevention and care engagement, such as knowledge and stigma. Both are highly salient barriers to infectious disease care and disease understanding, precursors to evaluating one's risk and need to, for example, accept vaccination. To address this gap, we developed and validated the Mpox Stigma Scale (MSS) and Mpox Knowledge Scale (MKS).

Methods

As part of a full-scale clinical trial, we offered an optional mpox survey to participants who self-identified as African American or Black, were 18-29 years old, and lived in Alabama, Georgia, or North Carolina (2023, N = 330). We calculated psychometric properties through confirmatory factor analyses (CFA) and applied Comparative F

SUBMITTER: Budhwani H 

PROVIDER: S-EPMC11389315 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature